Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
70.71-0.58 (-0.81%)
At close: 04:00PM EDT
71.06 +0.35 (+0.49%)
After hours: 07:41PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Outside Bar (Bullish)

Outside Bar (Bullish)

Previous Close71.29
Open71.03
Bid70.72 x 1000
Ask71.49 x 900
Day's Range70.13 - 71.37
52 Week Range53.22 - 80.59
Volume7,730,396
Avg. Volume9,644,953
Market Cap150.984B
Beta (5Y Monthly)0.42
PE Ratio (TTM)23.49
EPS (TTM)3.01
Earnings DateOct 26, 2022
Forward Dividend & Yield2.16 (3.03%)
Ex-Dividend DateOct 06, 2022
1y Target Est81.44
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-20% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BMY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Bristol-Myers Squibb Company
    Analyst Report: Bristol-Myers Squibb CompanyBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more
Advertisement
Advertisement